Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

      ( print page 28704)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. 

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Comprehensive Minority Institution Cancer Center Partnership.                     

*Date:*                         June 10-12, 2007.                     

*Time:*                         7 p.m. to 11 p.m. (June 10), 8 a.m. to 5 p.m. (June 11 and 12).                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.                     

*Contact Person:*                         Gerald G. Lovinger, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892-8329,  301-496-7897,                         *lovingeg@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Clinical Studies Special Emphasis Panel.                     

*Date:*                         June 18-19, 2007.                     

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.                     

*Contact Person:*                         Majed M. Hamawy, PhD, MBA, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8135, Bethesda, MD 20852, 301-594-5659,                         *mh101v@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Cancer Sample Preparation/Detection and Diagnosis.                     

*Date:*                         June 21, 2007.                     

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                     

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7141, Bethesda, MD 20892-7405, 301-496-7575,                         *palekarl@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Innovations in Cancer Sample Preparation.                     

*Date:*                         June 21, 2007.                     

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                     

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7141, Bethesda, MD 20892-7405, 301-496-7575,                         *palekarl@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis (U01).                     

*Date:*                         July 10-11, 2007.                     

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Marriott Bethesda Suites, 6711 Democracy Blvd., Bethesda, MD 20817.                     

*Contact Person:*                         C. Michael Kerwin, PhD, MPH, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8057, Bethesda, MD 20892-8329, 301-496-7421,                         *kerwinm@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: May 15, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy. 

[FR Doc. 07-2541 Filed 5-21-07; 8:45 am] 

BILLING CODE 4140-01-M